Mark J. Metrokotsas: President & CEO and Chairman of the Board
Mr. Metrokotsas has extensive and wide-ranging experience in the research, development and marketing of animal health care products and has served in executive capacities for major US pharmaceutical companies (Bayer, Bristol-Meyers-Squibb and Merck). He has established national distribution operations and private label product lines as well as directed the introduction of new equine vaccines, equine diagnostics and equine prostaglandins. The majority of his forty-seven year participation in the animal health business has been devoted to emerging products and market development with particular emphasis in the equine and small animal areas.
Clifford J. Alexander: Corporate Secretary
Mr. Alexander is a partner of the Washington, DC law firm of Kirkpatrick & Lockhart, LLP, specializing in corporate and securities law. Mr. Alexander’s practice includes representation of trust departments, investment companies, broker dealers and investment advisers with respect to their organization and structure, federal regulations, ERISA matters, and systems for compliance with federal regulations. Mr. Alexander has extensive experience as counsel to various banking task forces and securities commissions, as well as specializing in investment company and securities law. He has served as Centaur’s Board Secretary and legal advisor since the company was founded.
Dr John H. Abeles, MD: Director
Dr. Abeles is President of MedVest, Inc., a venture capital firm founded in 1980. He has considerable experience in the founding and development of biomedical companies. Previously, Dr. Abeles was a Vice President of Pharmaceutical Research at Kidder Peabody, Inc. and has held senior executive positions at Sterling Drug, Pfizer and Revlon Health. Dr. Abeles has been a Director of the Company since its inception.
Jeffrey O. Boily: Director
Mr. Boily is a serial entrepreneur and investor focused on life sciences. He is the non-executive Chairman of ProteaPex Therapeutics, a firm researching and developing innovative animal health therapeutics. Most recently he was President and CEO of the Center for Animal Health Innovation which focused on identifying and funding breakthrough technologies. Previous to this, he was CEO of BioWizard, a VC funded research and information firm for biomedical scientists. He gained large company executive experience at Abbott, Rogers and Wyeth including Fort Dodge Animal Health. He holds an M.B.A. from the John Molson School of Business, Concordia U., Montreal and a B.S. in biology from the U. of Ottawa. He also serves on the Board of Directors of various healthcare companies.
Russell B. Clark: Director
Mr. Clark was a partner of HC Wainwright and Co., where he was involved with venture capital and private placements. He is a lifetime Board Member of the US Equestrian Team and was formerly the Treasure of the Masters of Fox Hounds Association of America. He was appointed Chairman of the North American chapter of the British Field Sports Society (BFSS). Mr. Clark also trains, rides, breeds and races horses, and has been a Director of the Company since its inception.
H.D. Leth: Director
Mr. Leth has been President and CEO of Unavet, Inc., a manufacturer of animal health products since 1987. Board member and partner of Mid America Travel Services since 1992. He has held a variety of sales/marketing and management positions with Monsanto, W.R. Grace, West AGRO, and ICI Americas for 18+ years prior to joining Unavet.
Dr. Thomas Overbay, DVM: Director
Dr. Overbay, is a Partner at Expedite, a privately held animal health consulting firm. Prior to forming Expedite, Dr. Overbay has served as the senior business development officer for a major animal health company and has served in similar roles with a contract services provider and start-up animal health companies in the US and internationally. In addition to business development, Dr. Overbay’s background of veterinary practice, technical services, and sales management provides him with a unique perspective of the scientific, financial, and legal aspects of innovative technologies. Dr. Overbay has successfully brought to market a number of products arising from universities, government agencies, human hospitals, start-up companies (both human and veterinary), and multinational pharmaceutical and chemical companies. Dr. Overbay holds a veterinary degree from the Virginia-Maryland Regional College of Veterinary Medicine.
Dr. James D. Smith, DVM: Director
Dr. Smith was Vice President and a partner of Hagyard, Davidson & McGee, one of the leading equine veterinary firms in Lexington, Kentucky. Dr. Smith is also a co-owner of Pegasus Stud, and co-chairman of the Kentucky Equine Drug Council. He received his DVM from Kansas State University. Dr. Smith has been a Director of the Company since December 1990.